TABLE 3.

Antimicrobial susceptibilities of B. pseudomallei strains^a

Antibiotic	MIC (μg/ml)
	1026b	Bp50	Bp227	Bp58	Bp173	Bp174	Bp175	Bp207	Bp216	Bp250
Gentamicin	512	2	256	2	2	2	2	2	2	2
Kanamycin	64	4	64	4	4	4	4	4	4	4
Spectinomycin	2,048	64	1,024	64	64	64	64	64	64	64
Streptomycin	>2,048	16	2,048	16	16	16	16	16	16	16
Clarithromycin	128	8	64	32	32	16	2	0.5	0.5	4
Erythromycin	128	8	128	32	32	16	2	0.5	0.5	4
Clindamycin	>4,096	4,096	2,048	>4,096	>4,096	>4,096	512	128	128	4,096
Ciprofloxacin	0.5	0.5	0.25	2	2	2	0.13	0.03	0.03	0.5
Norfloxacin	4	4	2	16	16	8	1	0.25	0.25	4
Ofloxacin	2	2	2	8	8	4	0.5	0.13	0.13	1
Doxycycline	0.5	0.25	0.13	1	1	0.5	0.03	0.016	0.016	0.25
Tetracycline	0.5	0.25	0.25	1	1	0.5	0.06	0.03	0.03	0.13
Chloramphenicol	8	8	4	16	16	16	4	2	2	4
Carbenicillin	512	512	512	512	512	512	512	512	512	512
Ceftazidime	4	4	2	4	4	4	4	4	4	4
Acriflavine	32	16	16	64	64	32	1	0.5	0.5	16

^aThe genotypes of the tested strains were as follows: Bp50, 1026b Δ(amrRAB-oprA); Bp58, Bp50 ΔbpeR; Bp173, Bp58 with mini-Tn7T; Bp174, Bp58 with mini-Tn7T expressing bpeR from its own promoter; Bp175, Bp58 with mini-Tn7T expressing bpeR from the P1 promoter; Bp207, Bp50 Δ(bpeAB-oprB); Bp216, Bp207 with mini-Tn7T; Bp227, 1026b Δ(bpeAB-oprB); Bp250, Bp207 with mini-Tn7T expressing 1026b bpeAB-oprB from its own promoter.